Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia. - Wikidata - wikimedia - TriplyDB

Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.

Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.

http://www.wikidata.org/entity/Q34196506

about

The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study Dopamine receptor activation increases HIV entry into primary human macrophages Meta-Analysis of the COMT Val158Met Polymorphism in Major Depressive Disorder: Effect of Ethnicity.Time and time again: temporal processing demands implicate perceptual and gating deficits in the HIV-1 transgenic rat.Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge.Neuroimaging of HIV-associated neurocognitive disorders (HAND)Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes.Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes.Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.Substance use in older HIV-infected patients.Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions.Immunoneuropathogenesis of HIV-1 clades B and C: role of redox expression and thiol modification.Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport.Alcohol abuse and HIV infection: role of DRD2 Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter.HIV Subtypes B and C gp120 and Methamphetamine Interaction: Dopaminergic System Implicates Differential Neuronal Toxicity.Role of Sigma Receptor in Cocaine-Mediated Induction of Glial Fibrillary Acidic Protein: Implications for HAND Reduced neural specificity in middle-aged HIV+ women in the absence of behavioral deficits.HIV-1 Tat and cocaine mediated synaptopathy in cortical and midbrain neurons is prevented by the isoflavone Equol.Psychostimulant Abuse and HIV Infection: cocaine, methamphetamine, and "bath salts" cathinone analogues.Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice.Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding.Interplay between Wnt/β-catenin signaling and HIV: virologic and biologic consequences in the CNS.Mechanism(s) involved in opioid drug abuse modulation of HAND HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS.Abbreviated Goal Management Training Shows Preliminary Evidence as a Neurorehabilitation Tool for HIV-associated Neurocognitive Disorders among Substance Users.Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice.P73 and age-related diseases: is there any link with Parkinson Disease?Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice Role of Histidine 547 of Human Dopamine Transporter in Molecular Interaction with HIV-1 Tat and Dopamine Uptake 18O proteomics reveal increased human apolipoprotein CIII in Hispanic HIV-1+ women with HAART that use cocaine Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals.Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms.Effects of conditional central expression of HIV-1 tat protein to potentiate cocaine-mediated psychostimulation and reward among male mice.Epigenetics, drugs of abuse, and the retroviral promoter.

P2860

Q26777952-10803748-3D8A-4C17-A35F-31497E8050B3 Q27015965-F35C34F4-674B-40F7-9DD9-A637430B2E9C Q28487323-D8AA9F8D-9B81-4DF0-A888-B9A10A106600 Q28543414-8A95CB89-16B4-441D-8921-8CCDD9483A20 Q30277686-23D9A2A4-1FBF-4465-A757-FB76A68CF7B8 Q30431943-9480FCA6-0505-482F-A04C-9AD7EAF9EE39 Q30445058-B4CA3941-8659-4E17-B565-76B61DEA5257 Q30452291-6160E593-71A1-4DB1-ABBB-95B1057F2973 Q30854917-EDB8BAC3-2BF9-440B-8F9E-5B3FB889D16E Q33554713-67AB570B-DBF8-42C7-B29A-B34EA20A6F4E Q33660210-C46094C0-D12F-44DA-A54A-964143AB9DA7 Q33808035-76626CCD-A841-449B-BB39-CE05966C7E5C Q34247817-37669B75-5B28-4E27-A5CB-A257518844CC Q34343025-C96B39ED-9AC3-43A8-A9E2-2563700D1D5F Q34415545-3DB3787E-BE47-47B3-92A2-918818785407 Q34458860-D113C5B8-B4C1-468B-BF95-B74C690D36AA Q34989845-7D9AEC6F-D143-477B-BD5B-CC470D766476 Q35000860-76E5C150-38F1-4946-B90D-499DBD3B2D8E Q35450098-727828E0-FDF8-4829-80A8-2B6F23E83E46 Q35702075-649E1275-46BC-4D37-832B-9F2C70A33601 Q35901271-DFE3FE1B-DE3C-4FB2-A876-E34A334F1F12 Q35953242-02104220-60C8-4632-8294-64368F0988D0 Q36034222-FD989B93-43E6-437C-9373-B4AF1F2826AE Q36091506-EE7D097E-06C2-481B-BB62-397DBEE24EC6 Q36166289-25DBE027-BB53-4CD8-A630-55F4A5F6235B Q36350707-63B3AC60-CA27-4751-826B-08887524FF9D Q36429675-2FFD6570-7C11-4D73-BCE4-ED5B6BA9F5AD Q36456823-C6B5E543-90BC-4313-A86E-CBCD618E7FC1 Q36590733-43145E75-21C5-4AEA-80BE-6683A4A37D77 Q36634233-DB5C8A1E-43DC-4D3D-89B7-5441867D6CC3 Q36711680-5042166E-0809-4A31-94D7-19FF7E326EC3 Q36718290-A582AFFF-2BFD-4F64-A479-ACFEDD60233F Q36736367-4766D621-E19C-44B2-B200-E40BF0980461 Q36821772-E1B5D2EC-98B7-418A-BB91-787E64D8FB38 Q36960223-1D132115-F5AA-4A0F-8AF4-B390568D77CC Q37161083-F629AA64-37E0-400C-B864-038101879B18 Q37188241-A3026314-84FB-427A-BABB-E1B69463BBD6 Q37300421-E7E96BE7-54E1-4C3B-A2CA-24821080C0C8 Q37409631-5DC61B1B-F0D7-4B35-9D39-3241E0254AF0 Q37425468-D1FA295B-DC90-4446-9735-85161DC7270D

P2860

Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.

http://www.wikidata.org/entity/Q34196506

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Drugs of abuse, dopamine, and ...... rders/HIV-associated dementia.

@ast

Drugs of abuse, dopamine, and ...... rders/HIV-associated dementia.

@en

Drugs of abuse, dopamine, and ...... rders/HIV-associated dementia.

@nl

type

label

Drugs of abuse, dopamine, and ...... rders/HIV-associated dementia.

@ast

Drugs of abuse, dopamine, and ...... rders/HIV-associated dementia.

@en

Drugs of abuse, dopamine, and ...... rders/HIV-associated dementia.

@nl

prefLabel

Drugs of abuse, dopamine, and ...... rders/HIV-associated dementia.

@ast

Drugs of abuse, dopamine, and ...... rders/HIV-associated dementia.

@en

Drugs of abuse, dopamine, and ...... rders/HIV-associated dementia.

@nl

P1433

Q34196506-C7832254-9C06-4E7E-9220-1C52C7F8B621

P1476

Q34196506-6ED04B29-0413-48F6-92FE-C2FBFC5A98F8

P2093

Q34196506-309D4CD2-4ED0-4C9E-ABE6-E43F11761E8E

Q34196506-709E39E3-CC71-4D22-A106-0BA01B986D53

Q34196506-E100C865-CC4B-4A56-AFBC-159B681F49BF

P2860

Q34196506-00537198-35D1-43C3-97AF-97D78CFA0A3A

Q34196506-01A36CEE-08DA-4617-89E4-E0C9A1552000

Q34196506-0BEC4C8E-E828-4033-8617-65FD5793FDC4

Q34196506-11378976-6F8D-4736-A0EC-15ED19061C6D

Q34196506-157A55D9-8972-488B-ACB8-CAD066FA119B

Q34196506-170C9D15-5457-4F6A-8C09-787C9B5B9FD1

Q34196506-1B8A06DB-92F1-472E-AFE4-38B5E2CC5E30

Q34196506-1F8EAE10-1805-4AFD-B62D-A272F8DAC126

Q34196506-207861DB-89FE-47A3-9C1D-D8CEC50A8D69

Q34196506-262B695D-33FA-490C-AB24-5B57CB5310E6

P2888

Q34196506-0C08AC1F-DC34-44DE-AF07-495BA1067021

P304

Q34196506-E5F15B5C-31F4-4109-8345-CB737FFC21F9

P31

Q34196506-B9AC4828-3516-4B19-AA7E-E368F6354F04

P356

Q34196506-9D4E890B-AE32-445C-8B53-9026C6DBAEF5

P433

Q34196506-B398EE43-3406-4F1B-A4DC-15B271FB9DC6

P478

Q34196506-470D4468-872C-4E6C-B281-2C228D62DA73

P577

Q34196506-2DA0718D-43BC-49A3-BDAD-A4329BB60DF2

P6179

Q34196506-BC1E83D3-7A13-498F-A3CA-E7FC5AE4512D

P698

Q34196506-58B1952A-DD74-417B-8D54-0A1A4D2C85A8

P921

Q34196506-6c460152-4cfb-46f0-8ab5-3a2b645d1f33

Q34196506-E2CC6695-1AB2-42B9-9DE3-4BBA18EB959F

P356

S12035-011-8195-Z

P1433

Molecular Neurobiology

P1476

Drugs of abuse, dopamine, and ...... rders/HIV-associated dementia.

@en

P2093

David Shurtleff

http://www.w3.org/2001/XMLSchema#string

Rao Rapaka

http://www.w3.org/2001/XMLSchema#string

Vishnudutt Purohit

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs

HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells

Chicken ovalbumin upstream promoter transcription factor, a transcriptional activator of HIV-1 gene expression in human brain cells

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

Cocaine receptors on dopamine transporters are related to self-administration of cocaine

Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1.

Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients.

Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens.

Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence

Anti-HIV drug distribution to the central nervous system.

P2888

s12035-011-8195-z

P304

102-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12035-011-8195-Z

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1006419397

http://www.w3.org/2001/XMLSchema#string

P698

21717292

http://www.w3.org/2001/XMLSchema#string

P921